Paris University to study medical applications of NanoArrayer
24 August 2006
Ames, Iowa, USA. The Université Pierre &
Marie Curie (UPMC) in Paris is evaluating the biological applications of
BioForce Nanosciences (BULLETIN BOARD: BFNH) NanoArrayer system for enabling
new nanotechnology applications. The evaluation is being carried out for the
French Centre National de la Recherche Scientifique (CNRS).
The NanoArrayer was installed in May in the laboratory of Dr. Fatiha
Nothias. "Our plan is to use the unique printing capabilities of the
NanoArrayer to pattern proteins associated with cell morphology
establishment and migration," said Dr Nothias. "Our end goal is to determine
the consequences of the interactions of neurons and glial cells with these
Other French research groups in the same institute have expressed
interest in utilizing the NanoArrayer to study how cells sense their
environment during the organization of the embryonic tissue.
Michael Lynch, Product Manager for the NanoArrayer, assisted with the
installation and training process. "The NanoArrayer enables protein
patterning in the significantly small dimensions required to study single
cell growth and development important in neuroscience, cancer biology, stem
cell research, genetic disease and more," he said. "This installation also
provided an opportunity to introduce NanoAndMore, our European distributor
for the NanoArrayer product line, to these new and exciting markets."
"This technology agreement partnership with UPMC and CNRS provides
BioForce with valuable new market applications of the NanoArrayer," said
Kerry Frey, BioForce COO. "Our goal is continued growth into emerging new
bionanotechnology markets in Europe and this placement, our second overseas
this year, continues our progress."